Merit Medical Systems, Inc. growth

Reported trailing growth, forward expectations and three-year compound growth rates.

Trailing growth

Year over year

Revenue: +11.2%
EBITDA: +14.7%
EBIT: +9.7%
EPS: +12.4%
Free cash flow: +44.8%
Operating cash flow: +32.1%

Forward estimates

Revenue: +7.6%
EBITDA: -13.9%
EPS: +80.2%

Three-year CAGR

Revenue: +9.6%
EBITDA: +22.4%
EBIT: +28.2%
Net income: +19.9%
EPS: +18.3%
Free cash flow: +45.3%

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.